
Anna Olsson-Brown
@aolssonbrown
Mum, Medical Oncology Consultant, IO toxicity specialist, CEO IOCN, passion for immunotherapy cancer care, onco-toxicology, realworld research and basset hounds
ID: 4899542776
11-02-2016 22:22:32
501 Tweet
1,1K Followers
223 Following

๐๏ธ The final episode of our Personalised Immunotherapy podcast series is here! ๐ Episode 3: The Future Potential Dr. Paolo A. Ascierto returns to discuss what lies ahead for personalised immunotherapy and its transformative possibilities in cancer care. ๐ Listen to the full series

So pleased to hear an experienced expert women talking about AI in healthcare. Enough of the #techbro RCP Cymru Wales Royal College of Physicians Anna Olsson-Brown

My Clinical Outcomes Ethan Basch Nature Medicine EORTC Quality of Life Group (QLG) EORTC Anna Olsson-Brown โThese findings demonstrate that symptom monitoring with PRO meaningfully improves clinical outcomes, the patient experience and utilization of services and should be included as a standard part of quality cancer clinical careโ

Labour of love for 2 years now published in Clinical Lung Cancer. Largest study on clinical and tumor immunophenotypic characteristics in older adults with NSCLC and PDL1>50. Phenomenal work by Biagio Ricciuti, MD PhD Joรฃo Alessi, MD Valentina Santo Adriana Barrichello, MD to take this to finish line!



Diagnosis and management of immune checkpoint inhibitor neurotoxicity requires close collaboration between oncologists, neurologists and other health care professionals. @freddievonberg Anna Olsson-Brown Heather Shaw NEONeurotox


๐ฃ Registration is now open for this year's Melanoma Focus Healthcare Professional Virtual Meeting! ๐ Friday 16th May 2025 ๐ Organised by Dr Anna Olsson-Brown (Anna Olsson-Brown) ๐ฆ Early bird rate ends: April 21st 2025 Register: buff.ly/42LTu76 #VRM2025


Rapid CNS Response from Tarlatamab in pts with ES SCLC & untreated BM JTO & JTO CRR: - 10 pt case series, relapsed SCLC - response/SD in 9/10 pts (incl. LMD) - tarlatamab had CNS activity in pts with up to 20BM, avoiding WBRT OncoAlert Lauren Averett Byers, MD #LCSM jto.org/article/S1556-โฆ

Really looking forward to the meeting tomorrow Melanoma Focus UK

๐๏ธ New Episode Alert! ImmunoBuddies Podcast โ Episode 143 "Manifest! The Future of Predictive Biomarkers for Treatment Response and Toxicity", Episode 1 of 3 with Zayd Tippu from The Francis Crick Institute What if we could predict how patients will respond to treatmentโor even anticipate


A patient self portrait of the experience of irAEs shown at ASCO-so very powerful and important. Great session on coordinating irAE care and how important it is โฆ-exciting to think we could do this internationally โฆASCOโฉ โฆASPIRE Community of Practiceโฉ โฆImmuno-Oncology Clinical Networkโฉ


Coding for irAEs may be a data game changer! โฆASPIRE Community of Practiceโฉ โฆImmuno-Oncology Clinical Networkโฉ




We are live at #UKOF25. Come and see us at our stand just outside Studio 1. Lot's of IOCN updates and also the obligatory freebies! The Immunobuddies Podcast Anna Olsson-Brown Ricky Frazer


Grab a cuppa and settle down to listen to the next episode of The Immunobuddies Podcast Episode 146: HLH Demystified! Not Another Triad of Doom! open.spotify.com/episode/24FNu7โฆ Ricky Frazer Anna Olsson-Brown Velindre Cancer Service #cancer
